Results 311 to 320 of about 162,800 (333)
Some of the next articles are maybe not open access.
The American Journal of Cardiology, 2010
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +3 more sources
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +3 more sources
Beta-blockers for hypertension
2007Two recent systematic reviews found first-line beta-blockers to be less effective in reducing the incidence of stroke and the combined endpoint of stroke, myocardial infarction, and death compared to all other antihypertensive drugs taken together. However, beta-blockers might be better or worse than a specific class of drugs for a particular outcome ...
C S, Wiysonge +6 more
openaire +2 more sources
Psychiatric Uses of Beta-blockers
Pharmacopsychiatry, 1980Beta-blocking agents have been used for many years in psychiatry. But many are suspicious about their mechanisms and therapeutic effects. In this review, the most part of clinical trials is reported and criticized. With the exception of anxiolytic effects, the other therapeutic effects are still questionable for many reasons, such as the methodology of
P Deniker, H Cuche
openaire +3 more sources
2017
Beta-blockers (β-blockers) are one of the most commonly used heart failure medications. They are known to improve survival in patients with congestive heart failure, cardiac hypertrophy, and reperfusion abnormalities. Some recent data illustrate its role in preventing chemotherapy-induced cardiotoxicity.
J.L. Zamorano Gómez +1 more
openaire +2 more sources
Beta-blockers (β-blockers) are one of the most commonly used heart failure medications. They are known to improve survival in patients with congestive heart failure, cardiac hypertrophy, and reperfusion abnormalities. Some recent data illustrate its role in preventing chemotherapy-induced cardiotoxicity.
J.L. Zamorano Gómez +1 more
openaire +2 more sources
Beta blockers and infarct size
Journal of Molecular and Cellular Cardiology, 1986Reduction of myocardial oxygen demand by beta blockers should be beneficial for treatment of the supply-demand imbalance of severe myocardial ischaemia leading to infarction. There is evidence that rate-pressure product, an index of myocardial oxygen demand, is an independent variable for determination of infarct size, and that reduction of rate ...
openaire +3 more sources
2014
Early studies of prophylactic perioperative beta-blockade (i.e., started prior to surgery to reduce adverse cardiovascular outcomes) suggested benefit and led to relatively widespread clinical use. However, a subsequent large randomized controlled clinical trial demonstrated harm and led to more conservative recommendations.
Kay M. Johnson, Paul B. Cornia
openaire +2 more sources
Early studies of prophylactic perioperative beta-blockade (i.e., started prior to surgery to reduce adverse cardiovascular outcomes) suggested benefit and led to relatively widespread clinical use. However, a subsequent large randomized controlled clinical trial demonstrated harm and led to more conservative recommendations.
Kay M. Johnson, Paul B. Cornia
openaire +2 more sources
Journal of Clinical Pharmacy and Therapeutics, 1984
P. E. Hall, M. J. Kendall, S. R. Smith
openaire +2 more sources
P. E. Hall, M. J. Kendall, S. R. Smith
openaire +2 more sources
Journal of Clinical Pharmacy and Therapeutics, 1983
S. Hutchison, L. M. Campbell
openaire +3 more sources
S. Hutchison, L. M. Campbell
openaire +3 more sources